Arrowhead Pharmaceuticals, Inc.

WebsiteDirections Contact us

$1.38
OFF

Arrowhead Pharmaceuticals (ARWR) Stock Price, News & Analysis

2 weeks from now

3 days ago · Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported ($1.38) …

marketbeat.com

$62.00
OFF

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) CFO ... - ETF …

2 weeks from now

Jan 8, 2025 · A number of brokerages recently commented on ARWR. Piper Sandler dropped their price target on Arrowhead Pharmaceuticals from $62.00 to $45.00 and set an …

etfdailynews.com

$18.91
OFF

Analysts Set Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) …

2 weeks from now

1 day ago · Shares of ARWR opened at $18.91 on Friday. The company has a quick ratio of 6.74, a current ratio of 6.74 and a debt-to-equity ratio of 2.06. The stock has a market cap of $2.35 …

etfdailynews.com

2%
OFF

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold

2 weeks from now

Jan 6, 2025 · JPMorgan Chase & Co. decreased its holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) by 7.2% in the 3rd quarter, according to the company in its …

marketbeat.com

75%
OFF

Arrowhead Pharmaceuticals (ARWR) P/E Ratio - Public.com

2 weeks from now

The P/E ratio for Arrowhead Pharmaceuticals (ARWR) is -3.78 as of Jan 13, 2025.This represents a decrease of-40.75% compared to its 12-month average P/E ratio of-6.38.A higher P/E ratio …

public.com

5%
OFF

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Down 2.5

2 weeks from now

Jan 6, 2025 · Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report)'s stock price fell 2.5% on Monday . The company traded as low as $19.27 and last traded at $19.30. 89,235 …

marketbeat.com

FAQs about Arrowhead Pharmaceuticals, Inc. Coupon?

Where can I buy shares of Arrowhead Pharmaceuticals?

Shares of ARWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Arrowhead Pharmaceuticals own? ...

How much does Arrowhead Pharmaceuticals (Arwr) earn?

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$205.27 million. ARWR has generated -$1.93 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? ...

Should you buy Arrowhead Pharmaceuticals (Arwr) in 2024?

In 2024, Arrowhead Pharmaceuticals's revenue was $3.55 million, a decrease of -98.52% compared to the previous year's $240.74 million. Losses were -$599.49 million, 192.0% more than in 2023. According to 12 analysts, the average rating for ARWR stock is "Buy." ...

How did Arrowhead Pharmaceuticals (Arwr) perform in a quarter?

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) posted its quarterly earnings data on Thursday, August, 8th. The biotechnology company reported ($1.38) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.80. The business's quarterly revenue was down 100.0% compared to the same quarter last year. ...

When is Arrowhead Pharmaceuticals's next earnings date?

Arrowhead Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 5th, 2024 based off prior year's report dates. When is Arrowhead Pharmaceuticals's earnings date? ...

What are the preclinical drug candidates for Arrowhead Pharmaceuticals Corp?

Arrowhead Pharmaceuticals Corp's preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart ... For comprehensive Arrowhead Pharmaceuticals Corp. stock information, visit Barron's. Access real-time ARWR stock price and news, along with in-depth analysis. ...